| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8309367 | Clinica Chimica Acta | 2018 | 7 Pages |
Abstract
Our results provide evidence regarding the putative intervention of modifier factors in the phenotypic variability reported for the first time in the PFIC3 disease and highlight the importance of an early administration of the UDCA as a good solution to ovoid the disease progression.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Boudour Khabou, Bahri Mahjoub, Véronique Barbu, Nassima Balhoudi, Amina Wardani, Mohamed Taher Sfar, Faiza Fakhfakh,